Two Sigma Advisers’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-574,732
| Closed | -$2.36M | – | 2989 |
|
|
2022
Q1 | $2.36M | Sell |
574,732
-91,800
| -14% | -$333K | 0.01% | 1164 |
|
|
2021
Q4 | $2.38M | Sell |
666,532
-503,800
| -43% | -$1.76M | 0.01% | 1106 |
|
|
2021
Q3 | $4.26M | Sell |
1,170,332
-140,900
| -11% | -$570K | 0.01% | 866 |
|
|
2021
Q2 | $5.72M | Buy |
1,311,232
+126,800
| +11% | +$517K | 0.02% | 800 |
|
|
2021
Q1 | $4.87M | Sell |
1,184,432
-40,200
| -3% | -$174K | 0.01% | 864 |
|
|
2020
Q4 | $4.89M | Sell |
1,224,632
-105,600
| -8% | -$342K | 0.01% | 830 |
|
|
2020
Q3 | $3.59M | Sell |
1,330,232
-323,300
| -20% | -$895K | 0.01% | 885 |
|
|
2020
Q2 | $4.55M | Buy |
1,653,532
+86,700
| +6% | +$242K | 0.01% | 837 |
|
|
2020
Q1 | $3.7M | Buy |
1,566,832
+178,900
| +13% | +$608K | 0.01% | 831 |
|
|
2019
Q4 | $6.52M | Buy |
1,387,932
+942,600
| +212% | +$3.86M | 0.02% | 736 |
|
|
2019
Q3 | $1.49M | Buy |
445,332
+3,800
| +0.9% | +$12.5K | ﹤0.01% | 1245 |
|
|
2019
Q2 | $1.45M | Buy |
441,532
+49,000
| +12% | +$142K | ﹤0.01% | 1345 |
|
|
2019
Q1 | $1.19M | Buy |
392,532
+68,900
| +21% | +$223K | ﹤0.01% | 1443 |
|
|
2018
Q4 | $880K | Buy |
323,632
+208,100
| +180% | +$686K | ﹤0.01% | 1542 |
|
|
2018
Q3 | $388K | Buy |
+115,532
| New | +$357K | ﹤0.01% | 1885 |
|
|
2018
Q2 | – | Sell |
-21,332
| Closed | -$47K | – | 2544 |
|
|
2018
Q1 | $47K | Sell |
21,332
-38,987
| -65% | -$87.8K | ﹤0.01% | 2257 |
|
|
2017
Q4 | $120K | Buy |
60,319
+4,134
| +7% | +$9K | ﹤0.01% | 2137 |
|
|
2017
Q3 | $182K | Buy |
56,185
+36,085
| +180% | +$111K | ﹤0.01% | 2071 |
|
|
2017
Q2 | $65K | Buy |
+20,100
| New | +$57K | ﹤0.01% | 2195 |
|
|
2016
Q3 | – | Sell |
-20,300
| Closed | -$21K | – | 2349 |
|
|
2016
Q2 | $21K | Buy |
20,300
+100
| +0.5% | +$97 | ﹤0.01% | 2024 |
|
|
2016
Q1 | $18K | Buy |
+20,200
| New | +$19.5K | ﹤0.01% | 2006 |
|
Other funds holding ATRS
Two Sigma Advisers's ATRS Position: Q2 2022 in Review
Two Sigma Advisers sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 574,732 shares — an estimated $2.36M sold.
Two Sigma Advisers first reported a position in ATRS in Q1 2016 and held it in 21 quarters. The position peaked at $6.52M in Q4 2019. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Two Sigma Advisers reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Two Sigma Advisers sold 574,732 Antares Pharma, Inc. shares in Q2 2022, an estimated $2.36M.
- Two Sigma Advisers first reported a position in Antares Pharma, Inc. in Q1 2016 and held it in 21 quarters.
- Two Sigma Advisers's Antares Pharma, Inc. position peaked at $6.52M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.